Role of collagenase clostridium histolyticum in Peyronie's disease

Overview of attention for article published in Biologics: Targets & Therapy, September 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 44 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 24 publications that cite this research output.

24

The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.

The Discontinuation Rate With Collagenase Clostridium histolyticum for Peyronie’s Disease in a High-volume Practice Is Unexpectedly High: Identifying Opportunities for Patient Care Improvement

Article in Urology (November 2023)

Evaluation of the Influence of Chromium and Zinc Ions on the Collagenolysis Process in Solutions by the Method of Dynamic Light Scattering

Article in Optics and Spectroscopy (October 2023)

Peyronie's disease response to intralesional collagenase clostridium histolyticum therapy is independent of baseline testosterone

Article in Andrology (September 2023)